Item 8.01 Other Events


Domestic Issuer Status

As of June 30, 2020, the last business day of the second quarter of Zai Lab Limited (the "Company"), the Company determined that it no longer qualified as a foreign private issuer. As a result, effective January 1, 2021, the Company is required to file periodic reports and registration statements on U.S. domestic issuer forms with the Securities and Exchange Commission (the "SEC"), which are more detailed and extensive in certain respects. In addition, the Company is required to comply with U.S. proxy requirements. The Company is also no longer eligible to rely upon exemptions from corporate governance requirements that are available to foreign private issuers or to benefit from other accommodations for foreign private issuers under the rules of the SEC or the Nasdaq. The Company's next Annual Report for the year ended December 31, 2020 will be filed as a domestic issuer, on Form 10-K.

Disclosure Channels to Disseminate Information

Investors and others should note that the Company may announce material information about its finances, product candidates, clinical trials and other matters to its investors using its investor relations website (http://www.zailaboratory.com/in1/index.aspx) in addition to SEC filings, press releases, public conference calls and webcasts. The Company uses these channels to communicate with the Company's shareholders and the public about the Company and other issues. It is possible that the information the Company posts on these channels could be deemed to be material information. Therefore, the Company encourages investors, the media, and others interested in the Company to review the information it posts on the Company's investor relations website (referenced above) in addition to following its press releases, SEC filings, public conference calls, and webcasts.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses